Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
GeGe R. Clements
Observed names:
Clements, GeGe R,
G Clements,
GeGe Clements
Institution:
Philadelphia College of Osteopathic Medicine
Observed institutions:
Philadelphia College of Osteopathic Medicine,
National Institutes of Health,
University of Ottawa,
Children's Hospital of Eastern Ontario,
Western Infirmary,
The Alfred Hospital,
National Cancer Institute,
Center for Cancer Research,
University of Glasgow
show all 9
ORCID:
0009-0003-6843-5991
Observed ORCID:
0009-0003-6843-5991
OpenAlex ID:
A5011297694
Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
1975
·
J Menezes
, W Leibold
, et al.
·
PubMed
·
430
Evidence for previous hepatitis B virus infection in alcoholic cirrhosis.
1981
·
P R Mills
, E A Follett
, et al.
·
BMJ
·
65
PDF
Coxsackie B virus infection in coronary care unit patients.
1983
·
D O'Neill
, J D McArthur
, et al.
·
Journal of Clinical Pathology
·
29
PDF
Development of Personalized Strategies for Precisely Battling Malignant Melanoma
2024
·
Armond J. Isaak
, GeGe R. Clements
, et al.
·
International Journal of Molecular Sciences
·
17
Myocardial infarction and the normal arteriogram—possible role of viral myocarditis
1985
·
D O'Neill
, J D McArthur
, et al.
·
Postgraduate Medical Journal
·
10
Epicardial deletion of Crk and CrkL alters the cardiac transcriptome and cardiac metabolism to influence exercise capacity in mice
2026
·
Alessia Bradley
, Esmeralda Zere
, et al.
·
Physiology
A Model for Crk and CrkL-mediated Downregulation of Circadian Clock Genes for Enhanced Energetic Efficiency and Exercise Tolerance
2026
·
Clements, GeGe R
, Sobolewski, Madyson L
, et al.
·
Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine)
Abstract 5869: Investigation of molecular alterations associated with double resistance to BRAF and MEK inhibition in melanoma
2024
·
Armond J. Isaak
, GeGe R. Clements
, et al.
·
Cancer Research
Safety and Immunogenicity of Parainfluenza Type 3 (PIV3) Subunit Vaccine in Children 24 to 36 Months of Age. • 725
1997
·
J King
, F Diaz-Mitoma
, et al.
·
Pediatric Research
Show more works
View as search
Works count:
9
Citation count:
551
H-index:
5
I10-index:
5
Year
Topic
Type